The research in the field of biology of ageing has grown over the past decades, due to the increase in human life expectancy (Hansen and Kennedy 2016) . Increased lifespan has not seen a parallel increase in healthspan with accompanying economic burden. Ageing is an important risk factor for several musculoskeletal, neurodegenerative and metabolic disorders (Waite et al. 1996; Brown and Goljanek-Whysall 2015) . As our understanding of the biology of ageing has increased, manipulation of the various cellular processes and the underlying signaling pathways have been considered as potential therapeutic targets for lifespan extension and more importantly health span. These include cellular senescence and numerous molecular pathways associated with mitochondrial dysfunction, as well as reactive oxygen species or lipid-associated cellular processes. Interventions aimed at improving health span in the older age have concentrated on diet and exercise, with recent research highlighting their importance in early years, and even in utero, as well as wide variety of compounds, some of which are thought to be molecules considered senolytics (able to eliminate senescent cells) or antioxidants (Zhu et al. 2015; Kirkland et al. 2017; Cabreiro et al. 2013; Duque-Guimarães D et al. 2017) .
This special issue is a collection of articles that contribute to the latest knowledge in this area inspired by the British Society for Research into Ageing 2016 Annual Scientific Meeting in Durham under the topic: ''Evolution and the Biology of Ageing''. This theme was designed to bring together those studying molecular and cellular aspects of ageing with those looking at human and animal ageing, both in the lab and in the wild. The different rates of ageing across species is a product of evolution and fully understanding ageing requires bringing together researchers working at different scales.
Age-related musculoskeletal decline is associated with lower quality of life of older people. Muscle wasting during ageing is associated with physical frailty, therefore it is important to maintain muscle mass and function in older age. Exercise and diet remain the only interventions aimed at maintaining muscle mass and strength (Brown and GoljanekWhysall 2015) . The article by Francis et al. demonstrates that combined progressive resistance training and protein supplementation beyond habitual intakes in older women is an effective strategy to improve muscle strength and extended gait speed in healthy older women (Francis et al. 2017a) . The article continues the theme of muscle wasting by discussing the importance of variability in the components of muscle health, tools of assessment and protocols for measurement. Francis et al. propose an evaluation method of lean tissue mass and skeletal muscle and suggest that knee extensor torque measurement represents the force generating capacity of the thigh and therefore muscle strength. The authors also suggest that measures of function which allow a greater maximum performance are most appropriate for establishing age-related differences in muscle function (Francis et al. 2017b ). The mechanisms of muscle ageing are further discussed in the manuscript by Brown et al. demonstrating interesting data on that replicatively aged myoblasts are not anabolically resistant, as previously hypothesized, but are capable of efficient repair, however this depends on different than in un-aged cells signaling pathways compared with non-aged myoblasts (Brown and GoljanekWhysall 2015) . The authors show that leucine and bHydroxy b-methylbutyric acid, supplements used for recovery of muscle damage following exercise in humans, positively affect myoblast migration and may enhance muscle regeneration. The molecular mechanisms of muscle loss are further shown to be associated with high fat mass, sarcopenic obesity in the article by Saini et al. (2017) . These data highlight novel pathways associated with in vitro models of lipotoxicity and cytotoxicity. Specifically, the authors show the importance of fatty acid levels, high levels of which can be associated with cell death and reduced differentiation during muscle regeneration and therefore may be associated with sarcopenic obesity.
Osteoporosis, characterised by progressive bone weakening and an increased risk of fractures, is one of the most prevalent bone disorders associated with ageing. Interestingly, predisposing risk factors of this disease are thought to be established during childhood and adolescence. The review by Santos et al. (2017) discusses exercise interventions implemented during maturation as highly beneficial as part of a long-term strategy to maintain bone mass and delay the onset of osteoporosis. Early life interventions are also discussed in the review by Duque-Guimarães and Ozanne (2017), which focuses on the early life nutrition effects on the decline in physiological function during ageing. The review highlights emerging data, especially molecular mechanisms, from model organism and epidemiological studies, demonstrating that exposure to a suboptimal nutritional environment in utero can have long term effects on adult health. Some of the mechanisms discussed include epigenetics modifications, oxidative stress, DNA damage and telomere shortening. Potential strategies targeting these mechanisms are also discussed. The importance of lipid homeostasis is explored in the review by Ademowo et al. (2017) , which discusses the disruption of lipid homeostasis, due to, at least in part, mitochondrial dysfunction and elevated ROS formation in progression of cell senescence, which is known to contribute significantly to age-related pathologies. Ademowo and colleagues propose that emerging therapeutic approaches targeting mitochondrial uncoupling, reduction of mitochondrial oxidative stress, inflammatory lipid synthesis, modulation of lipid transport or storage and finally elimination of senescent cells from tissues could be attractive approaches against agerelated disorders. The review by Bettedi and Foukas (2017) examines the dysregulation of metabolic homeostasis, associated with mitochondrial homeostasis, during ageing which is usually manifested as age-related obesity, impaired insulin sensitivity and glucose and lipid homeostasis. Metabolic pathologies are thought to be limiting the potential for lifespan extension and this review explores pharmacological interventions and natural and synthetic compounds aimed at improving health span showing potential in achieving beneficial metabolic effects.
Cellular senescence has been widely implicated as a hallmark of ageing, related to the physiological deterioration, increased mortality and decreased in fertility during ageing associated with metabolic and mitochondrial dysfunction. Jones and Vaupel (2017) take an interesting position on the phenomenon of senescence. The authors describe the history of the theoretical ideas on the evolution of senescence, focusing on the increasing empirical data argues that senescence may not be as universal a feature of ageing as once thought and that a diversity of demographic trajectories exists. Moreover, supported by observations supporting the idea that negligible senescence and even negative senescence (improvement) occur, the authors suggest that senescence is not inevitable.
The articles presented within this special issue will hopefully be of significant interest to biogerontologists interested in the molecular pathways underlying ageing, as well as studying interventions aiming at enabling healthy ageing. What emerges from these articles is the complexity of the ageing process with senescence being not only a negative but potentially positive process in certain situations. Exercise and diet remain effective interventions against functional decline during ageing, with early life nutrition and physical activity playing key roles in tissue homeostasis in later life. Although potential effective therapeutic interventions have been identified, such as antioxidant supplementation, further understanding of the nature of their mechanism of action and the timing of the supplementation, will enable the development of more effective interventions to improve lifespan and health span of humans.
